Document is current
Any future updates will be listed below
-
Authors
Hiller, Benjamin M.
Marmion, David J. https://orcid.org/0000-0003-4575-2380
Thompson, Cayla A.
Elliott, Nathaniel A. https://orcid.org/0000-0001-6749-5624
Federoff, Howard
Brundin, Patrik
Mattis, Virginia B. https://orcid.org/0000-0001-5204-5604
McMahon, Christopher W.
Kordower, Jeffrey H. https://orcid.org/0000-0001-8629-3294
-
Funding
Funding for this research was provided by:
FUJIFILM Cellular Dynamics, Inc.
- License Information
-
More Information
Article History
Received: 12 July 2021
Accepted: 22 March 2022
First Online: 21 April 2022
Competing interests
: C.A.T., C.W.M., V.B.M., and N.A.E. are current or former employees of FUJIFILM Cellular Dynamics Inc., and B.M.H., D.J.M., P.B., and J.H.K. are current or former consultants of FUJIFILM Cellular Dynamics, Inc. P.B. has also received commercial support as a consultant from Axial Therapeutics, Calico Life Sciences, CuraSen, Idorsia Pharmaceuticals, IOS Press Partners, LifeSci Capital LLC, Lundbeck A/S, and Living Cell Technologies LTD. P.B. has received commercial support for grants/research from Roche and Teva/Lundbeck and has ownership interests in Acousort AB and Axial Therapeutics. J.H.K. has ownership interests in Brainstorm Inc. and is a paid consultant for Clintrex Inc., Seelos, Inc., Exicure, Inc., Inhibikase Inc., AskBio, Inc., Encora Inc., and Amydis Inc. H.F. is a current employee of Brooklyn ImmunoTherapeutics and has financial interests in Athena Neuroscience and is a paid consultant for Souvien Therapeutics and Perthera Inc.
